|
Market Closed -
Other stock markets
|
After hours 02:47:58 am | |||
| 768.00 USD | -3.58% |
|
767.69 | -0.04% |
EPS & Dividend: Regeneron Pharmaceuticals, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | 3.672 | 3.906 | 4.471 |
| Rate of return | - | - | - | - | - | 0.46% | 0.49% | 0.56% |
| EPS 2 | 30.52 | 71.97 | 38.22 | 34.77 | 38.34 | 40.79 | 39.53 | 48 |
| Distribution rate | - | - | - | - | - | 9% | 9.88% | 9.32% |
| Reference price 2 | 483.11 | 631.52 | 721.49 | 878.29 | 712.33 | 796.55 | 796.55 | 796.55 |
| Nbr of stocks (in thousands) | 1,05,544 | 1,04,556 | 1,06,802 | 1,06,347 | 1,07,590 | 1,02,599 | 1,02,599 | - |
| Announcement Date | 05/02/21 | 04/02/22 | 03/02/23 | 02/02/24 | 04/02/25 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: Regeneron Pharmaceuticals, Inc.
| 20/11/2025 | Quarterly 0.88 USD |
| 18/08/2025 | Quarterly 0.88 USD |
| 20/05/2025 | Quarterly 0.88 USD |
| 20/02/2025 | Quarterly 0.88 USD |
Upcoming events: Regeneron Pharmaceuticals, Inc.
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.46% | 0.49% | 19.53x | 2.56x | 5.29x | |
| -.--% | -.--% | 56.58x | 7.61x | 14.96x | |
| 0.55% | 0.57% | 42.74x | 4.44x | 6.63x | |
| 2.65% | 2.88% | 22.2x | 2.78x | 4.06x | |
| -.--% | -.--% | 18.08x | 1.49x | 2.97x | |
| -.--% | -.--% | 17.25x | 3.64x | 3.41x | |
| -.--% | 0.02% | 81.91x | 7.95x | 9.72x | |
| - | - | 376.68x | 68.1x | 114.3x | |
| -.--% | -.--% | -22.56x | -7.29x | 32.45x | |
| - | - | - | - | - | |
| Average | 0.46% | 0.49% | 68.05x | 10.14x | 21.53x | |
| Weighted average by Cap. | 0.65% | 0.69% | 50.09x | 7.06x | 13.76x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition